Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

This study has been completed.
Sponsor:
Collaborators:
Sanofi-Synthelabo
OSI Pharmaceuticals
Hoffmann-La Roche
Genentech, Inc.
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00123851
First received: July 25, 2005
Last updated: April 27, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Publications: